- Home
- PVH vs ACAD Comparison
PVH vs ACAD Comparison
Compare PVH & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVH
- ACAD
- Stock Information
- Founded
- PVH 1881
- ACAD 1993
- Country
- PVH United States
- ACAD United States
- Employees
- PVH 28000
- ACAD 654
- Industry
- PVH Apparel
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- PVH Consumer Discretionary
- ACAD Health Care
- Exchange
- PVH Nasdaq
- ACAD Nasdaq
- Market Cap
- PVH 3.4B
- ACAD 3.9B
- IPO Year
- PVH N/A
- ACAD 2004
- Fundamental
- Price
- PVH $71.32
- ACAD $23.53
- Analyst Decision
- PVH Buy
- ACAD Buy
- Analyst Count
- PVH 15
- ACAD 18
- Target Price
- PVH $92.40
- ACAD $27.94
- AVG Volume (30 Days)
- PVH 1.1M
- ACAD 1.7M
- Earning Date
- PVH 08-26-2025
- ACAD 08-06-2025
- Dividend Yield
- PVH 0.20%
- ACAD N/A
- EPS Growth
- PVH N/A
- ACAD N/A
- EPS
- PVH 7.34
- ACAD 1.37
- Revenue
- PVH $8,684,600,000.00
- ACAD $996,283,000.00
- Revenue This Year
- PVH $2.94
- ACAD $13.28
- Revenue Next Year
- PVH $2.01
- ACAD $10.88
- P/E Ratio
- PVH $9.73
- ACAD $17.19
- Revenue Growth
- PVH N/A
- ACAD 22.42
- 52 Week Low
- PVH $59.28
- ACAD $13.40
- 52 Week High
- PVH $113.47
- ACAD $25.23
- Technical
- Relative Strength Index (RSI)
- PVH 44.57
- ACAD 61.47
- Support Level
- PVH $75.26
- ACAD $22.40
- Resistance Level
- PVH $77.66
- ACAD $24.06
- Average True Range (ATR)
- PVH 2.04
- ACAD 0.72
- MACD
- PVH -0.22
- ACAD 0.09
- Stochastic Oscillator
- PVH 18.07
- ACAD 76.96
About PVH PVH Corp.
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, about 1,400 stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.